ALLMedicine™ Glucose Tolerance Testing Center

Mar 11th, 2023 - Cyclin-dependent kinase 1 (CDK1)/cyclin B1 phosphorylates many of the same substrates as mTORC1 (a key regulator of glucose metabolism), including the eukaryotic initiation factor 4E-binding protein 1 (4E-BP1). Only mitotic CDK1 phosphorylates 4E-...

Mar 10th, 2023 - Non-alcoholic fatty liver disease (NAFLD) is the most common hepatic disorder in the Western world, and is a leading cause of liver-related morbidity and mortality. Excessive caloric intake and specific nutritional components have been implicated ...

Mar 6th, 2023 - Our aim in this study was to identify challenges and gaps in Canadian practices in screening, diagnosis and treatment of cystic fibrosis-related diabetes (CFRD), with the goal of informing a Canadian-specific guideline for CFRD. We conducted an on...

Mar 3rd, 2023 - A. Hypotheses and Specific Aims: Cystic Fibrosis Related Diabetes Mellitus (CFRD) has been identified by the CF community as one of the top ten priorities for CF research1. In CF, clinical decline due to dysglycemia begins early, prior to the diag...

Feb 17th, 2023 - Objective: The aim of this study was to characterize current diabetes screening practices in the first trimester of pregnancy in the United States, evaluate patient characteristics and risk factors associated with early diabetes screening, and com...

Mar 10th, 2023 - Non-alcoholic fatty liver disease (NAFLD) is the most common hepatic disorder in the Western world, and is a leading cause of liver-related morbidity and mortality. Excessive caloric intake and specific nutritional components have been implicated ...

Mar 3rd, 2023 - A. Hypotheses and Specific Aims: Cystic Fibrosis Related Diabetes Mellitus (CFRD) has been identified by the CF community as one of the top ten priorities for CF research1. In CF, clinical decline due to dysglycemia begins early, prior to the diag...

Feb 8th, 2023 - This multicentre prospective study will evaluate the ability of the FatHealth technology to correctly identify individuals with pre-diabetes and diabetes, validating the technology against the current gold-standard diagnostic method, oral glucose ...

Jan 26th, 2023 - Gestational diabetes affects approximately 5-10% of pregnancies and its prevalence continues to increase as rates of obesity and metabolic disease increase in reproductive age women. Women diagnosed with gestational diabetes carry an increased ris...

Jan 13th, 2023 - Background: Type 2 diabetes mellitus (T2DM) is a condition characterized by insulin resistance and progressive failure of the insulin-secreting beta-cells. Previously considered a disease of adults, it is now becoming increasingly prevalent in chi...

Feb 7th, 2022 - More sleep was linked with fewer calories consumed, a single-center randomized clinical trial showed. Compared with controls, young adults who were overweight and habitually slept less than 6.5 hours a night slept an extra 1.2 hours on average aft...

Feb 1st, 2021 - Women who’ve had gestational diabetes are 40% more likely to develop coronary artery calcification later in life than are women haven’t, and attaining normal glycemic levels doesn’t diminish their midlife risk for atherosclerotic cardiovascular di.

Mar 1st, 2020 - GRAPEVINE, TEX. – Early postpartum glucose tolerance testing for women with gestational diabetes resulted in a 99% adherence rate, with similar sensitivity and specificity as the currently recommended 4- to 12-week postpartum testing schedule.

Mar 1st, 2020 - GRAPEVINE, TEX. – Early postpartum glucose tolerance testing for women with gestational diabetes resulted in a 99% adherence rate, with similar sensitivity and specificity as the currently recommended 4- to 12-week postpartum testing schedule.

Jun 9th, 2019 - The monoclonal antibody teplizumab may delay the onset of type 1 diabetes in individuals at high risk, according to research presented at the annual scientific sessions of the American Diabetes Association. In this study, 76 first-degree relatives.